Dexpramipexole for Moderate-to-Severe Eosinophilic Asthma

For Patients and Families For Healthcare Professionals

Are you a healthcare professional?

Go back

Knopp Disclaimer

Knopp’s pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are undergoing clinical study to verify their safety and effectiveness.

Dexpramipexole An oral approach to eosinophilic asthma

Knopp Disclaimer